Cambridge biotech Healx stands on the cusp of history after dosing the first patient with a rare and deadly cancer with a ...

Life sciences giant AstraZeneca has supported the global expansion of The Healthcare Businesswomen’s Association into ...

Tristel plc, which makes infection prevention products utilising proprietary chlorine dioxide technology, hoisted revenues ...

Stansted Airport is on the road to Morocco, or set to take a more stellar highway to be precise. To quote the immortal line ...

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British ...

Sortera Bio Ltd has spun out of the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to pioneer a Deep ...

Cambridge-based anti-ageing biotech Shift Bioscience has set up a team and facilities in Canada to serve North America. The ...

Broken String Biosciences, a leader in advancing gene editing safety, has opened its Catalyst Early Access Program (EAP) for ...

Luminance, a Cambridge-based pioneer in Legal-Grade™ AI, has raised $75 million in a Series C funding round, taking the total ...

BMZ Group, a leading European manufacturer of cross-industry lithium-ion battery systems, is offering the opportunity of a ...

Experienced finance chief William J. Kullback has joined the board of Cambridge biotech business Nuclera as a Non Executive ...

Life science company Epitopea, rooted in Cambridge UK and both Montreal and Quebec in Canada, has clinched a licensing deal ...